Johnson & Johnson’s talcum powder, or baby powder, is a product that has been in many people’s linen closets, bathrooms, nurseries, and gym bags for decades. This astringent powder is used for many practical and cosmetic reasons including as a deodorizer, shampoo, and rash preventer. For decades, women have used it on their genital area after showering or playing sports to prevent moisture and odor. In recent years, a statistical link was found between women who use baby powder in this way and ovarian cancer. While a causal link has not been established, hundreds of women have filed Johnson & Johnson Talcum Powder lawsuits.
If you have been diagnosed with ovarian cancer or lost a loved one to this disease, and you believe it is connected to the use of talcum powder, contact Staver Accident Injury Lawyers, P.C. today. Our Chicago product liability attorneys can evaluate your case and help file your claim. Call us today at (312) 236-2900 to schedule a free initial consultation.
There is a divide in the medical and scientific communities regarding the connection between talcum powder and an increased risk of ovarian cancer. There are studies that have shown no difference in the chance of a women being diagnosed with ovarian cancer with the consistent use of baby powder. Contrastingly, other studies have shown a slight increase in the incidents of ovarian cancer in women who regularly used talcum powder for an extended period of time.
Amanda Fader, a gynecologic oncologist at Johns Hopkins University who did not participate in any of the studies, stated “The scientific body of literature is not compelling at this time to support a strong association between talcum powder and ovarian cancer, let alone to say any one specific case was associated with powder,” The Washington Post reported.
The American Cancer society also states on their website that the results of studies have been mixed and do not show a definite connection or causal relationship. Additionally, neither the National Cancer Institute nor the U.S. Food and Drug Administration have found a link between the use of talcum powder and ovarian cancer.
However, the information available to juries across the country have been enough for multiple rulings against Johnson & Johnson, and have led to sizeable jury awards.
According to the U.S. Judicial Panel on Multidistrict Litigation, as of September 15, there were at least 878 talcum powder lawsuits pending in the U.S. District Court for the District of New Jersey, where all of the federal ovarian claim lawsuits involving Johnson & Johnson have been centralized. However, this is only a fraction of the number of lawsuits in which Johnson & Johnson has been named regarding this issue. In a previous quarterly report, the company disclosed it was sued approximately 4,800 times regarding the talcum powder-ovarian cancer issue.
The women suing Johnson & Johnson are claiming the company failed to warn consumers regarding the potential long-term risks of using talcum powder on or near the genitals despite this potential risk being known as early as the 1970s. The plaintiffs have also alleged that the company failed to provide the proper warnings because of their desire for greater profits.
In the first trial to move forward in California, the jury awarded the plaintiff, a woman with terminal ovarian cancer, $417 million. In Missouri, while one jury was in favor of Johnson & Johnson, four other juries decided in favor of the plaintiffs, and they were awarded between $55 and $110 million.
If you have been diagnosed with ovarian cancer and you have regularly used Johnson & Johnson’s talcum powder products, contact a Chicago product liability lawyer right away. You may have the right to file a product liability claim against the business to seek compensation for your physical, psychological, and financial injuries.